Spinogenix, Inc.
About Spinogenix, Inc.
The startup develops biopharmaceuticals that target synaptic proteins to reverse synapse loss associated with brain injuries and neurodegenerative diseases. By restoring brain connections, the company enables patients to regenerate synapses, improving cognitive function and quality of life.
The startup develops biopharmaceuticals that target synaptic proteins to reverse synapse loss associated with brain injuries and neurodegenerative diseases. By restoring brain connections, the company enables patients to regenerate synapses, improving cognitive function and quality of life.
What does Spinogenix, Inc. do?
The startup develops biopharmaceuticals that target synaptic proteins to reverse synapse loss associated with brain injuries and neurodegenerative diseases. By restoring brain connections, the company enables patients to regenerate synapses, improving cognitive function and quality of life.
Where is Spinogenix, Inc. located?
Spinogenix, Inc. is based in San Diego, United States.
When was Spinogenix, Inc. founded?
Spinogenix, Inc. was founded in 2016.
How much funding has Spinogenix, Inc. raised?
Spinogenix, Inc. has raised $13.8M.
- Location
- San Diego, United States
- Founded
- 2016
- Funding
- $13.8M
- Employees
- 4 employees